Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome

Oncogene

Volumn 30, Issue 9, 2011, Pages 1046-1058

  Henry, L A ^a   Johnson, D A ^a   Sarrio D ^a   Lee, S ^a   Quinlan, P R ^b   Crook, T ^a   Thompson, A M ^b   Reis Filho, J S ^a   Isacke, C M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

breast cancer; CD105; endoglin; ErbB2; MCF10A; TGF

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ANTHRACYCLINE DERIVATIVE; AP 1510; AZACITIDINE; ENDOGLIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SHORT HAIRPIN RNA; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ACINAR CELL; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER INHIBITION; CANCER INVASION; CELL COMPARTMENTALIZATION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL STRAIN; CELL STRAIN MCF 10; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOSKELETON; DNA METHYLATION; DOWN REGULATION; ENDOTHELIUM CELL; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TUMOR CELL;

ANIMALS; ANTIGENS, CD; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA METHYLATION; FEMALE; GENE SILENCING; HUMANS; LUNG; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 79952283351     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.488     Document Type: Article

References (40)

1. Aranda V, Haire T, Nolan ME, Calarco JP, Rosenberg AZ, Fawcett JP et al. (2006). Par6-aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control. Nat Cell Biol 8: 1235-1245. (Pubitemid 44660588)
2. Barbara NP, Wrana JL, Letarte M. (1999). Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta super-family. J Biol Chem 274: 584-594.
3. Bernabeu C, Conley BA, Vary CP. (2007). Novel biochemical pathways of endoglin in vascular cell physiology. J Cell Biochem 102: 1375-1388. (Pubitemid 350223941)
4. Bernabeu C, Lopez-Novoa JM, Quintanilla M. (2009). The emerging role of TGF-beta superfamily coreceptors in cancer. Biochim Biophys Acta 1792: 954-973.
5. Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, Engel ME et al. (2001). Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 12: 27-36. (Pubitemid 32060576)
6. Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, Massague J et al. (1992). Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 267: 19027-19030.
7. Conley BA, Koleva R, Smith JD, Kacer D, Zhang D, Bernabeu C et al. (2004). Endoglin controls cell migration and composition of focal adhesions: function of the cytosolic domain. J Biol Chem 279: 27440-27449. (Pubitemid 38812583)
8. Craft CS, Romero D, Vary CP, Bergan RC. (2007). Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway. Oncogene 26: 7240-7250. (Pubitemid 350085322)
9. Debnath J, Brugge JS. (2005). Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer 5: 675-688. (Pubitemid 41486361)
10. Feng XH, Derynck R. (2005). Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 21: 659-693. (Pubitemid 41740650)
11. Guerrero-Esteo M, Sanchez-Elsner T, Letamendia A, Bernabeu C. (2002). Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II. J Biol Chem 277: 29197-29209.
12. Ikediobi ON, Davies H, Bignell G, Edkins S, Stevens C, O'Meara S et al. (2006). Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. Mol Cancer Ther 5: 2606-2612. (Pubitemid 44848987)
13. Illingworth RS, Bird AP. (2009). CpG islands-'a rough guide'. FEBS Lett 583: 1713-1720.
14. Ishibashi O, Ikegame M, Takizawa F, Yoshizawa T, Moksed MA, Iizawa F et al. (2010). Endoglin is involved in BMP-2-induced osteogenic differentiation of periodontal ligament cells through a pathway independent of Smad-1/5/8 phosphorylation. J Cell Physiol 222: 465-473.
15. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ et al. (1996). Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13: 189-195.
16. Klingbeil P, Natrajan R, Everitt G, Vatcheva R, Marchio C, Palacios J et al. (2010). CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification. Breast Cancer Res Treat 120: 95-109.
17. Lebrin F, Goumans MJ, Jonker L, Carvalho RL, Valdimarsdottir G, Thorikay M et al. (2004). Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. Embo J 23: 4018-4028. (Pubitemid 39472423)
18. Lee NY, Blobe GC. (2007). The interaction of endoglin with beta-arrestin2 regulates transforming growth factor-beta-mediated ERK activation and migration in endothelial cells. J Biol Chem 282: 21507-21517. (Pubitemid 47099970)
19. Massague J. (2008). TGFbeta in Cancer. Cell 134: 215-230.
20. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE et al. (1994). Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiec-tasia type 1. Nat Genet 8: 345-351.
21. Moustakas A, Heldin CH. (2005). Non-Smad TGF-beta signals. J Cell Sci 118: 3573-3584.
22. Muthuswamy SK, Li D, Lelievre S, Bissell MJ, Brugge JS. (2001). ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat Cell Biol 3: 785-792. (Pubitemid 32842683)
23. Mythreye K, Blobe GC. (2009). The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrest-in2-mediated activation of Cdc42. Proc Natl Acad Sci USA 106: 8221-8226.
24. Oxmann D, Held-Feindt J, Stark AM, Hattermann K, Yoneda T, Mentlein R. (2008). Endoglin expression in metastatic breast cancer cells enhances their invasive phenotype. Oncogene 27: 3567-3575. (Pubitemid 351793804)
25. Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL. (2005). Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 307: 1603-1609. (Pubitemid 40354739)
26. Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR et al. (2008). TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133: 66-77. (Pubitemid 351442989)
27. Perez-Gomez E, Villa-Morales M, Santos J, Fernandez-Piqueras J, Gamallo C, Dotor J et al. (2007). A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis. Cancer Res 67: 10268-10277. (Pubitemid 350070800)
28. Quintanilla M, Ramirez JR, Perez-Gomez E, Romero D, Velasco B, Letarte M et al. (2003). Expression of the TGF-beta coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis. Oncogene 22: 5976-5985. (Pubitemid 37179945)
29. Roberts AB, Wakefield LM. (2003). The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci USA 100: 8621-8623. (Pubitemid 36899145)
30. Rodriguez-Barbero A, Obreo J, Alvarez-Munoz P, Pandiella A, Bernabeu C, Lopez-Novoa JM. (2006). Endoglin modulation of TGF-beta1-induced collagen synthesis is dependent on ERK1/2 MAPK activation. Cell Physiol Biochem 18: 135-142.
31. Romero D, Terzic A, Conley BA, Craft CS, Jovanovic B, Bergan RC et al. (2010). Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration. Carcinogenesis 31: 359-366.
32. Sanz-Rodriguez F, Guerrero-Esteo M, Botella LM, Banville D, Vary CP, Bernabeu C. (2004). Endoglin regulates cytoskeletal organization through binding to ZRP-1, a member of the Lim family of proteins. J Biol Chem 279: 32858-32868. (Pubitemid 39014746)
33. Scharpfenecker M, van Dinther M, Liu Z, van Bezooijen RL, Zhao Q, Pukac L et al. (2007). BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 120: 964-972. (Pubitemid 46638511)
34. Scherner O, Meurer SK, Tihaa L, Gressner AM, Weiskirchen R. (2007). Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling. J Biol Chem 282: 13934-13943. (Pubitemid 47100463)
35. Seton-Rogers SE, Lu Y, Hines LM, Koundinya M, LaBaer J, Muthuswamy SK et al. (2004). Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells. Proc Natl Acad Sci USA 101: 1257-1262. (Pubitemid 38182676)
36. Shi Y, Massague J. (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700. (Pubitemid 36724933)
37. ten Dijke P, Goumans MJ, Pardali E. (2008). Endoglin in angiogenesis and vascular diseases. Angiogenesis 11: 79-89.
38. Webb DJ, Parsons JT, Horwitz AF. (2002). Adhesion assembly, disassembly and turnover in migrating cells - over and over and over again. Nat Cell Biol 4: E97-100.
39. Wong VC, Chan PL, Bernabeu C, Law S, Wang LD, Li JL et al. (2008). Identification of an invasion and tumor-suppressing gene, Endoglin (ENG), silenced by both epigenetic inactivation and allelic loss in esophageal squamous cell carcinoma. Int J Cancer 123: 2816-2823.
40. Zhang YE. (2009). Non-Smad pathways in TGF-beta signaling. Cell Res 19: 128-139.